Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma

Rohan Joshi, Qasim Husain, Benjamin R. Roman, Jennifer Cracchiolo, Yao Yu, Jillian Tsai, Julie Kang, Sean McBride, Nancy Y. Lee, Luc Morris, Ian Ganly, Viviane Tabar, Marc A. Cohen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Esthesioneuroblastoma (ENB) is a rare neuroendocrine tumor. The purpose of this study was to compare the Kadish, tumor-node-metastasis (TNM), and Dulguerov's modified TNM staging in order to determine the impact of the stage on primary surgical treatment selection, margin status, and survival. Methods: The National Cancer Database (NCDB) was used to identify patients diagnosed with ENB between 2004 to 2015. Patients were excluded based on the ability to properly stage their disease as well as the availability of treatment data. Results: Eight-hundred eighty-three patients had sufficient data for analysis. On multivariate analysis, age and government insurance were associated with primary surgical treatment, whereas tumor stage, gender, race, hospital type and volume, and comorbidity score were not. Age, charlson-deyo comorbidity (CDCC) score, hospital volume, and nodal status were found to be predictors of survival. Multivariate-analysis controlling for stage failed to demonstrate clear survival differences between staging in both TNM and Kadish systems. T-stage and the presence of regional nodal metastasis were associated with an increased risk of positive margins on multivariate analysis. Conclusion: Although primary surgical management and positive margins can be predicted by certain patient and tumor factors, clinical staging systems for ENB poorly predict prognosis over a 10-year horizon.

Original languageEnglish (US)
Pages (from-to)130-142
Number of pages13
JournalJournal of Surgical Oncology
Volume119
Issue number1
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Olfactory Esthesioneuroblastoma
Neoplasm Metastasis
Neoplasms
Multivariate Analysis
Survival
Comorbidity
Neuroendocrine Tumors
Insurance
Therapeutics
Databases

Keywords

  • esthesioneuroblastoma
  • national cancer database
  • sinonasal malignancies
  • sinonasal neoplasm

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Joshi, R., Husain, Q., Roman, B. R., Cracchiolo, J., Yu, Y., Tsai, J., ... Cohen, M. A. (2019). Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma. Journal of Surgical Oncology, 119(1), 130-142. https://doi.org/10.1002/jso.25293

Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma. / Joshi, Rohan; Husain, Qasim; Roman, Benjamin R.; Cracchiolo, Jennifer; Yu, Yao; Tsai, Jillian; Kang, Julie; McBride, Sean; Lee, Nancy Y.; Morris, Luc; Ganly, Ian; Tabar, Viviane; Cohen, Marc A.

In: Journal of Surgical Oncology, Vol. 119, No. 1, 01.01.2019, p. 130-142.

Research output: Contribution to journalArticle

Joshi, R, Husain, Q, Roman, BR, Cracchiolo, J, Yu, Y, Tsai, J, Kang, J, McBride, S, Lee, NY, Morris, L, Ganly, I, Tabar, V & Cohen, MA 2019, 'Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma', Journal of Surgical Oncology, vol. 119, no. 1, pp. 130-142. https://doi.org/10.1002/jso.25293
Joshi, Rohan ; Husain, Qasim ; Roman, Benjamin R. ; Cracchiolo, Jennifer ; Yu, Yao ; Tsai, Jillian ; Kang, Julie ; McBride, Sean ; Lee, Nancy Y. ; Morris, Luc ; Ganly, Ian ; Tabar, Viviane ; Cohen, Marc A. / Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma. In: Journal of Surgical Oncology. 2019 ; Vol. 119, No. 1. pp. 130-142.
@article{37928cd3fd364928b61f9dd716e8ffc3,
title = "Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma",
abstract = "Background: Esthesioneuroblastoma (ENB) is a rare neuroendocrine tumor. The purpose of this study was to compare the Kadish, tumor-node-metastasis (TNM), and Dulguerov's modified TNM staging in order to determine the impact of the stage on primary surgical treatment selection, margin status, and survival. Methods: The National Cancer Database (NCDB) was used to identify patients diagnosed with ENB between 2004 to 2015. Patients were excluded based on the ability to properly stage their disease as well as the availability of treatment data. Results: Eight-hundred eighty-three patients had sufficient data for analysis. On multivariate analysis, age and government insurance were associated with primary surgical treatment, whereas tumor stage, gender, race, hospital type and volume, and comorbidity score were not. Age, charlson-deyo comorbidity (CDCC) score, hospital volume, and nodal status were found to be predictors of survival. Multivariate-analysis controlling for stage failed to demonstrate clear survival differences between staging in both TNM and Kadish systems. T-stage and the presence of regional nodal metastasis were associated with an increased risk of positive margins on multivariate analysis. Conclusion: Although primary surgical management and positive margins can be predicted by certain patient and tumor factors, clinical staging systems for ENB poorly predict prognosis over a 10-year horizon.",
keywords = "esthesioneuroblastoma, national cancer database, sinonasal malignancies, sinonasal neoplasm",
author = "Rohan Joshi and Qasim Husain and Roman, {Benjamin R.} and Jennifer Cracchiolo and Yao Yu and Jillian Tsai and Julie Kang and Sean McBride and Lee, {Nancy Y.} and Luc Morris and Ian Ganly and Viviane Tabar and Cohen, {Marc A.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/jso.25293",
language = "English (US)",
volume = "119",
pages = "130--142",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma

AU - Joshi, Rohan

AU - Husain, Qasim

AU - Roman, Benjamin R.

AU - Cracchiolo, Jennifer

AU - Yu, Yao

AU - Tsai, Jillian

AU - Kang, Julie

AU - McBride, Sean

AU - Lee, Nancy Y.

AU - Morris, Luc

AU - Ganly, Ian

AU - Tabar, Viviane

AU - Cohen, Marc A.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Esthesioneuroblastoma (ENB) is a rare neuroendocrine tumor. The purpose of this study was to compare the Kadish, tumor-node-metastasis (TNM), and Dulguerov's modified TNM staging in order to determine the impact of the stage on primary surgical treatment selection, margin status, and survival. Methods: The National Cancer Database (NCDB) was used to identify patients diagnosed with ENB between 2004 to 2015. Patients were excluded based on the ability to properly stage their disease as well as the availability of treatment data. Results: Eight-hundred eighty-three patients had sufficient data for analysis. On multivariate analysis, age and government insurance were associated with primary surgical treatment, whereas tumor stage, gender, race, hospital type and volume, and comorbidity score were not. Age, charlson-deyo comorbidity (CDCC) score, hospital volume, and nodal status were found to be predictors of survival. Multivariate-analysis controlling for stage failed to demonstrate clear survival differences between staging in both TNM and Kadish systems. T-stage and the presence of regional nodal metastasis were associated with an increased risk of positive margins on multivariate analysis. Conclusion: Although primary surgical management and positive margins can be predicted by certain patient and tumor factors, clinical staging systems for ENB poorly predict prognosis over a 10-year horizon.

AB - Background: Esthesioneuroblastoma (ENB) is a rare neuroendocrine tumor. The purpose of this study was to compare the Kadish, tumor-node-metastasis (TNM), and Dulguerov's modified TNM staging in order to determine the impact of the stage on primary surgical treatment selection, margin status, and survival. Methods: The National Cancer Database (NCDB) was used to identify patients diagnosed with ENB between 2004 to 2015. Patients were excluded based on the ability to properly stage their disease as well as the availability of treatment data. Results: Eight-hundred eighty-three patients had sufficient data for analysis. On multivariate analysis, age and government insurance were associated with primary surgical treatment, whereas tumor stage, gender, race, hospital type and volume, and comorbidity score were not. Age, charlson-deyo comorbidity (CDCC) score, hospital volume, and nodal status were found to be predictors of survival. Multivariate-analysis controlling for stage failed to demonstrate clear survival differences between staging in both TNM and Kadish systems. T-stage and the presence of regional nodal metastasis were associated with an increased risk of positive margins on multivariate analysis. Conclusion: Although primary surgical management and positive margins can be predicted by certain patient and tumor factors, clinical staging systems for ENB poorly predict prognosis over a 10-year horizon.

KW - esthesioneuroblastoma

KW - national cancer database

KW - sinonasal malignancies

KW - sinonasal neoplasm

UR - http://www.scopus.com/inward/record.url?scp=85056821793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056821793&partnerID=8YFLogxK

U2 - 10.1002/jso.25293

DO - 10.1002/jso.25293

M3 - Article

VL - 119

SP - 130

EP - 142

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 1

ER -